Market Research Report
Global TEVAR Market 2016-2020
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||351691|
Delivery time: 1-2 business days
|Global TEVAR Market 2016-2020|
|Published: February 3, 2016||Content info:||
TEVAR is a minimally invasive procedure done to repair thoracic aortic aneurysms (TAAs) with reduced recovery time and improved survival rates. TAAs are usually asymptomatic, but can lead to life-threatening hemorrhage and rupture. It is divided into three categories based on the location of the problem: aortic arch, ascending aortic, and descending thoracic aneurysms. Non-infectious aortitis, inherited syndromes, atherosclerosis, and infections cause most TAAs. TEVAR prevents rupture of an aneurysm and replaces it with a synthetic or thoracic stent graft through small incisions in the groin.
Technavio's analysts forecast the global TEVAR market to grow at a CAGR of 8.66% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global thoracic endovascular aneurysm repair (TEVAR) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of stent grafts required for TEVAR surgeries.
The market is divided into the following segments based on geography:
Technavio's report, Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.